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Abstract
Background: This study evaluated the use of comprehensive geriatric assessment (CGA) in older patients
undergoing pacemaker implantation.
Methods: In this prospective cohort, CGA was performed in 197 patients ≥75 years at pacemaker implantation and
yearly thereafter. CGA embraced the following domains: cognition, mobility, nutrition, activities of daily living
(ADLs), and falls (with or without loss of consciousness). Based on comorbidities, the Charlson comorbidity index
(CCI) was calculated. For predictive analysis, logistic regression was used.
Results: During a mean follow-up duration of 2.4 years, the incidence rates of syncope decreased from 0.46 to 0.04
events per year (p < 0.001), and that of falls without loss of consciousness from 0.27 to 0.15 (p < 0.001) before vs.
after implantation. Sixty-three patients (32.0%) died. Impaired mobility (OR 2.60, 95%CI 1.22–5.54, p = 0.013),
malnutrition (OR 3.26, 95%CI 1.52–7.01, p = 0.002), and a higher CCI (OR per point increase 1.25, 95%CI 1.04–1.50,
p = 0.019) at baseline were significant predictors of mortality. Among 169 patients who survived for more than 1
year and thus underwent follow-up CGA, CGA domains did not deteriorate during follow-up, except for ADLs. This
decline in ADLs during follow-up was the strongest predictor of later nursing home admission (OR 9.29, 95%CI
1.82–47.49, p = 0.007). Higher baseline age (OR per year increase 1.10, 95%CI 1.02–1.20, p = 0.018) and a higher
baseline CCI (OR per point increase 1.32, 95%CI 1.05–1.65, p = 0.017) were associated with a decline in ADLs during
follow-up.
Conclusions: CGA is useful to detect functional deficits, which are associated with mortality or nursing home
admission after pacemaker implantation. The present study seems to support the use of CGA in older patients
undergoing pacemaker implantation as functional deficits and falls are amenable to geriatric interventions.
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Background
In industrialized countries, the use of pacemakers in
older patients will increase in the future due to
epidemiologic and demographic changes [1]. Previous
studies have shown that pacemaker implantations have
favorable effects on mortality, syncope and quality of life
in older patients [2–5]. However, these outcomes reflect
only part of important outcomes in older patients, since
functional outcomes after cardiologic interventions are
similarly important [6, 7]. Moreover, it has been shown
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that functional limitations prior to interventions are as-
sociated with mortality and worse functional outcomes
[6, 8–13]. Pre-procedural functional limitations as well
as functional outcomes after interventions are usually
ascertained using comprehensive geriatric assessment
(CGA) [14]. CGA covers important functional domains,
such as cognition, mobility, nutrition, activities of daily
living, or falls (with or without loss of consciousness)
[14].
Though a recent position paper on pacemaker man-
agement suggests performing geriatric assessment in
older patients, it is only rarely used in clinical routine
[1]. This underuse may be partially explained by a lack
of good evidence in current literature. To the best of the
authors’ knowledge, no previous study evaluated CGA in
older patients undergoing pacemaker implantation. Des-
pite an extensive literature search, the authors found
only one small study that evaluated cognitive function in
19 patients undergoing pacemaker implantation [15].
The present study therefore aimed to fill this scientific
gap and to evaluate CGA in a prospective cohort of
older patients undergoing pacemaker implantation.
Methods
Study population
Consecutive patients ≥75 years of age undergoing pace-
maker implantation and being followed at the Heart
Center Lucerne (Lucerne, Switzerland) between March
1st, 2012, and March 31st, 2017, were eligible for this
prospective cohort study. The following patients were
excluded from the study: first, patients who refused
study participation and did not provide a signed in-
formed consent; second, patients in whom baseline as-
sessment was unfeasible due to logistic reasons. Patients
with intracardiac cardioverter devices (ICDs) were also
excluded. The final study population consisted of all pa-
tients in whom pacemaker implantation and baseline
examination were performed during the study period.
This study complies with the Declaration of Helsinki
and was approved by the local ethics committee.
Baseline evaluation
All participating patients received extensive cardiologic
baseline examination according to current guidelines
[16]. Patient history was recorded including symptoms,
cardiovascular risk factors, medication, prior cardiovas-
cular events, as well as comorbidities. Physical examin-
ation included standard parameters such as body weight,
height and blood pressure. Based on the number of co-
morbidities, the Charlson comorbidity index (CCI) was
calculated [17].
In addition, all participating patients underwent CGA
involving instruments for functional status. CGA con-
sisted of the following validated instruments: Mini
Mental State Exam (MMSE) for cognitive function [18],
Timed Get Up and Go Test (TUG) for gait function
[19], Mini Nutritional Assessment (MNA) for nutritional
status [20], Basic Activities of Daily Living (BADL) [21],
and Instrumental Activities of Daily Living (IADL) [22].
The number of falls without loss of consciousness and/
or syncopes in the preceding 12months were assessed
using standardized questions. The instruments were di-
chotomized at standard cut points. The latter were de-
fined from the outset: MMSE at < 27 points (cognitive
impairment) vs. ≥27 points (normal cognitive function),
TUG at ≥20 s (mobility impairment) vs. < 20 s (normal
gait function), MNA at < 12 points (at risk of malnutri-
tion) vs. ≥12 points (not at risk of malnutrition) [18–20].
If there was one or more activity with a limitation,
BADL and IADL were considered abnormal [21, 22]. In
addition to the functional assessment, the emotional sta-
tus was assessed using the 5-item geriatric depression
scale (GDS), which was dichotomized at ≥2 points (at
risk of depression) vs. < 2 points (not at risk of depres-
sion) [23].
Pacemaker implantation
Pacemaker implantations were performed by five experi-
enced operators according to best clinical practice re-
specting the current guideline recommendation [16].
Dual chamber pacemakers were implanted in 159 pa-
tients, single chamber devices in 33 patients and 5 pa-
tients received a biventricular system.
Follow-up
A routine follow-up was performed yearly at the Heart
Center Lucerne in all participants. The study partici-
pants were invited by mail and/or phone. In case the
participants did not respond to the invitation, the treat-
ing general practitioner and/or registered relatives were
contacted. During the on-site visit, the pacemaker was
interrogated and patients underwent a cardiological
examination as well as CGA. CGA consisted of the same
instruments that were used at baseline. CGA also
assessed the number of falls without loss of conscious-
ness and/or syncopes since the baseline examination or
the last follow-up, respectively. In case of death phone
interviews were done with the treating general practi-
tioner and/or relatives to ascertain the circumstances.
Death and the time of death were crosschecked using
the official register of the local authorities.
Outcomes
Mortality was the main outcome and defined as overall
mortality from cardiac or non-cardiac causes. Changes
in the incidence of syncope and falls between the pre-
and post-implantation period was another outcome.
Syncope was defined as fall with a short period of
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unconsciousness, whereas a drop without loss of con-
sciousness was considered a fall. As a further outcome,
we determined the change of functional status between
baseline and follow-up comparing the single CGA do-
mains between baseline and follow-up. Based on BADL
and IADL, we defined the outcome decline in activities
of daily living (decline in ADLs), which corresponded to
a deterioration of ≥1 activity in the ability to perform
BADL and/or IADL between baseline and follow-up. Re-
garding the outcome nursing home admission, only new
admissions after pacemaker implantation were
considered.
Statistical analysis
First, we descriptively analyzed mortality, syncope and
falls without loss of consciousness during follow-up. Sec-
ond, to compare rates of syncope and falls during
follow-up with the pre-implantation period, incidence
rates were calculated and compared using the incidence
rate ratio (IRR) with its 95% confidence interval (CI).
Third, we descriptively analyzed the change of functional
status between baseline evaluation and last available
follow-up examination among patients who survived for
more than 1 year after pacemaker implantation and thus
had at least one follow-up CGA. Fourth, in order to
compare the functional status during follow-up with
baseline, we used logistic regression reporting odds ra-
tios (ORs) with 95% CIs and p values. Models were done
unadjusted as well as adjusted for age, sex and the CCI.
Fifth, we separately analyzed the functional course
among surviving patients, who showed a baseline im-
pairment in the respective domain. The rational for this
analysis was the high clinical relevance of this subgroup;
furthermore, due to the ceiling effect of the assessment
instruments, improvements could only be shown for this
subgroup. Sixth, we used multivariable logistic regres-
sion to identify associations between potentially predict-
ive variables and the outcomes. The potentially
predictive variables were selected a priori based on clin-
ical considerations (i.e., age, sex, CCI, and the CGA do-
mains). In the logistic models, the CCI was used as
categorized variable with a range from 1 to 9, and the
CGA domains were dichotomized at the standard cut
points. The area under the receiver operating character-
istic curve (AUROC) was used to quantify predictive
ability. Finally, we performed sensitivity analyses. For
mortality prediction, we performed a sensitivity analysis
using a modified CCI without cardiovascular comorbidi-
ties, but adding cardiovascular comorbidities (i.e., NYHA
class, presence of coronary artery disease, previous myo-
cardial infarction, and heart failure) as single independ-
ent variables to the logistic model. For the prediction of
nursing home admission, we performed a further sensi-
tivity analysis retaining the deceased patients in the
regression model. Data were analyzed using Stata 12.1
(StataCorp LP, College Station, TX, USA).
Results
Study population
Between March 1st 2012 and March 31st 2017, 270 pa-
tients aged 75 years or older underwent pacemaker im-
plantation (Fig. 1). Fifty-three patients were initially
excluded: 42 patients refused participation, 11 did not
have a complete baseline assessment due to logistic
problems. Of 217 eligible patients, 11 (5.1%) refused
follow-up examination and 9 (4.1%) were lost to follow-
up. The study population finally consisted of 197
patients.
Baseline characteristics are shown in Table 1. Mean
age was 82.9 ± 4.9 years (range 75–95 years). Sinus node
disease, higher degree atrioventricular block and atrial
fibrillation were frequent ECG findings. Accordingly, the
most frequent indication for pacemaker implantation
was bradycardia (137 patients, 69.5%). Syncope as well
as falls without loss of consciousness were frequent
events in the 12 months preceding the pacemaker im-
plantation (Table 1). Thirty-seven patients (18.8%) have
suffered from severe injuries associated with the synco-
pal event or fall (e.g., bone fracture in 16 patients, bleed-
ing needing intervention in 10 patients, traumatic brain
injury in 8 patients, other serious injury in 3 patients).
Many of the patients had functional limitations based on
CGA (Table 1).
Mortality, syncope and falls in all study participants
During a mean follow-up of 2.4 ± 1.4 years and total ob-
servation time of 472 person-years, 63 patients (32.0%)
died. Most of these deaths (88.9%) were considered to be
of a non-cardiac origin (e.g., general weakness due to
age, infectious disease, and/or carcinoma).
During follow-up, 19 syncopes and 71 falls without
loss of consciousness occurred. Compared to the pre-
implantation period the incidence rate of syncope dra-
matically decreased from 0.46 to 0.04 events per year
(IRR 0.09, 95% CI 0.05–0.15, p < 0.001), as did falls with-
out loss of consciousness with a decreasing incidence
rate from 0.27 to 0.15 events per year (IRR 0.56, 95% CI
0.39–0.81, p < 0.001).
Functional course
Table 2 shows the changes in functional and emotional
status among the 169 patients with available follow-up
CGA. Overall, functional and emotional status were well
preserved until the last follow-up, with the exception of
activities of daily living. BADL and IADL showed a sig-
nificant deterioration over the study period.
An additional analysis of the subgroup of surviving pa-
tients with baseline impairment showed that relevant
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proportions of these patients improved in their func-
tional and emotional course. Among the 46 surviving
patients with cognitive impairment at baseline, 27 pa-
tients (58.7%) showed a cognitive improvement, 7 pa-
tients (15.2%) remained unchanged, and only 12 patients
(26.1%) showed a further deterioration. Among the 37
surviving patients with mobility impairment at baseline,
mobility improved in 21 patients (56.8%), remained un-
changed in 13 patients (35.1%), and deteriorated in only
3 patients (8.1%). Nutritional status improved in 36
(75.0%) of the 48 surviving patients with risk of malnu-
trition at baseline, remained unchanged in 9 patients
(18.8%), and deteriorated in only 3 patients (6.2%). Re-
garding BADL and IADL, improvements were found in
12 of 21 patients (57.1%) with BADL limitations and 22
of 70 patients (31.4%) with IADL limitations at baseline;
a deterioration was found in 6 patients (28.6%) for
BADL and 26 patients (37.1%) for IADL, respectively.
Regarding emotional status, an improvement was found
in 13 of 16 patients (81.3%), while 3 patients (18.7%)
remained stable and no patient deteriorated.
Predictive analyses
In the predictive analysis, impaired mobility (OR 2.60
[95% CI 1.22–5.54], p = 0.013; AUROC 0.63 [95% CI
0.56–0.70]), malnutrition (OR 3.26 [95% CI 1.52–7.01],
p = 0.002; AUROC 0.65 [95% CI 0.58–0.73]), a higher
CCI (OR per point increase 1.25 [95% CI 1.04–1.50],
p = 0.019; AUROC 0.68 [95% CI 0.60–0.75]), and age
(OR per year increase 1.08 [95% CI 1.00–1.16], p =
0.049; AUROC 0.62 [95% CI 0.53–0.70]) at baseline were
significant predictors of mortality after the pacemaker
implantation (Fig. 2). Of the 134 surviving patients, 13
patients (9.7%) were newly admitted to a nursing home.
The decline in ADLs from baseline to follow-up was
found to be the strongest predictor of later nursing
home admission (OR 9.29 [95% CI 1.82–47.49], p =
0.007; AUROC 0.72 [95% CI 0.61–0.84]), whereas the
baseline variables in the model (i.e., age, sex, CCI, and
CGA domains) were not predictive of the outcome. In a
logistic regression evaluating baseline factors associated
with the decline in ADLs, significant associations were
found for higher baseline age (OR per year increase 1.10
Fig. 1 Flow chart
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[95% CI 1.02–1.20], p = 0.018; AUROC 0.58 [95% CI
0.49–0.68]) and a higher CCI (OR per point increase
1.32 [95% CI 1.05–1.65], p = 0.017; AUROC 0.59 [95%
CI 0.49–0.68]).
Sensitivity analyses
Using cardiovascular comorbidities as single independ-
ent predictors in the model for mortality prediction, im-
paired mobility, malnutrition, and the modified CCI
were unvaried the significant predictors of mortality
after pacemaker implantation, whereas the cardiovascu-
lar comorbidities did not significantly predict mortality.
Including the deceased patients in the analysis for the
prediction of nursing home admission, the decline in
ADLs from baseline to follow-up remained the strongest
predictor of later nursing home admission (OR 9.92
[95% CI 2.12–46.48], p = 0.004).
Discussion
The results from this prospective cohort show that, apart
from higher age and higher comorbidity burden, im-
paired mobility and malnutrition were significantly asso-
ciated with mortality after pacemaker implantation.
Mortality in this cohort was high with nearly one of
Table 1 Baseline characteristics
Characteristic All study participants (N = 197)
Age, mean ± SD, years 82.9 ± 4.9
Female sex, n (%) 86 (43.7%)
Body Mass Index, mean ± SD, kg/m2 25.7 ± 4.2
Cardiovascular risk factors
Hypertension, n (%) 155 (78.7%)
Hypercholesterolemia, n (%) 60 (30.5%)
Current smoker, n (%) 17 (8.6%)
Diabetes, n (%) 30 (15.2%)
Positive family history, n (%) 24 (12.2%)
Medical history
Coronary artery disease, n (%) 92 (46.7%)
Previous myocardial infarction, n (%) 16 (8.1%)
Valvular heart disease, n (%) 92 (46.7%)
Hypertensive heart disease, n (%) 40 (26.9%)
Hypertrophic cardiomyopathy, n (%) 24 (12.2%)
Previous stroke, n (%) 25 (12.7%)
Previous syncope within last 12 months, n (%) 90 (45.7%)
Fall without loss of consciousness within last 12 months, n (%) 53 (26.9%)
Electrocardiogram
Sinus node disease, n (%) 49 (24.9%)
Atrioventricular block
- Second-degree, n (%) 39 (19.8%)
- Third-degree, n (%) 51 (25.9%)
Atrial fibrillation, n (%) 59 (29.9%)
Comprehensive geriatric assessment
Cognitive impairment (MMSE < 27 points), n (%) 84 (42.6%)
Mobility impairment (TUG ≥20 s), n (%) 71 (36.0%)
At risk of malnutrition (MNA < 12 points), n (%) 90 (45.7%)
BADL with ≥1 activity with limitation, n (%) 39 (19.8%)
IADL with ≥1 activity with limitation, n (%) 110 (55.8%)
Emotional assessment
At risk of depression (GDS ≥2 points), n (%) 34 (17.3%)
Comorbidity burden
Charlson comorbidity index ≥3, n (%) 98 (49.8%)
Abbreviations: BADL basic activities of daily living, GDS geriatric depression scale, IADL instrumental activities of daily living, MMSE mini mental state exam, MNA
mini nutritional assessment, TUG timed get up and go test
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three patients dying during the relatively short mean
follow-up duration of little more than 2 years. Pace-
maker implantation not only improved the occurrence
of syncope, but also led to a highly relevant decrease in
falls without loss of consciousness. Our study further
shows that functional status remains stable in surviving
patients after pacemaker implantation except for activ-
ities of daily living, which deteriorated during follow-up.
The decline in ADLs was the most important factor be-
ing significantly associated with nursing home admission
during follow-up.
Mortality after pacemaker implantation was high in
our cohort, but comparable to previous studies involving
similar patients [2–5, 24, 25]. Mortality, syncope and
quality of life of elderly patients undergoing pacemaker
implantation have been well investigated in these previ-
ous studies, but to our knowledge this is the first study
evaluating CGA in older patients undergoing pacemaker
implantation. This study documents the importance of
additionally assessing falls without loss of consciousness
and the functional course after pacemaker implantation
using standardized CGA instruments. This study there-
fore adds to a growing evidence from other surgical or
interventional procedures that CGA is important for the
assessment of functional outcomes as well as for out-
come prediction [6–13, 26].
This study has clinical implications. It demonstrated
that older malnourished patients with impaired mobility
have a greater risk of dying after a pacemaker implant-
ation. CGA is suited to detect these functional deficits.
Recent systematic analyses of randomized controlled
studies have shown that CGA and subsequent interven-
tions based on CGA improve prognosis and decrease
nursing home admissions among older patients [27, 28].
This study shows that a decline in ADLs during follow-
up increases the risk of nursing home admission. CGA
during follow-up detects this deterioration, which may
prompt interventions aiming at reversing the decline in
ADLs. Therefore, the present study seems to support the
use of CGA in older patients undergoing pacemaker
implantation.
This study also shows that a relevant proportion of pa-
tients with functional limitations at baseline recover
from these limitations after pacemaker implantation. We
presume that in some patients the functional limitations
are the consequence of hemodynamic compromises due
to the cardio-electric dysfunction leading to pacemaker
implantation. This study therefore underlines the im-
portance of performing pacemaker implantation even in
the oldest old.
This study has limitations. First, the findings of this
study are based on data from a single center. Therefore,
generalizability of the findings of the present study is
limited. Second, though the sample size was adequate
for most analyses, the number of study participants and
endpoints was probably too low for certain analyses. It is
conceivable that some of the non-significant results
might be the consequence of a type II error. Third, 9 of
the 217 patients (4.1%) included in the study cohort
were lost to follow-up without information on mortality,
which may have biased our follow-up results to a certain
extent. Fourth, as functional course could only be ana-
lyzed for patients, who did not die during the first year
of follow-up and thus underwent follow-up CGA, the re-
sults of functional course might be biased to some ex-
tent. However, we performed a sensitivity analysis for
Table 2 Functional and emotional course (N = 169)
Domain Baseline Follow-up Regression analysis
Unadjusted Adjusted a
N (%) N (%) OR (95% CI) b P value b OR (95% CI) b P value b
Cognition
Cognitive impairment (MMSE < 27 points) 64 (37.9%) 69 (40.8%) 1.13 (0.73–1.75) 0.578 1.15 (0.73–1.81) 0.560
Mobility
Mobility impairment (TUG ≥20 s) 55 (32.5%) 49 (29.0%) 0.85 (0.54–1.36) 0.502 0.85 (0.53–1.37) 0.504
Activities of daily living
BADL with ≥1 activity with limitation 29 (17.2%) 48 (28.4%) 1.92 (1.14–3.23) 0.015 2.18 (1.23–3.88) 0.008
IADL with ≥1 activity with limitation 90 (53.3%) 121 (71.6%) 2.21 (1.41–3.47) 0.001 2.59 (1.57–4.26) < 0.001
Nutrition
At risk of malnutrition (MNA < 12 points) 71 (42.0%) 60 (35.5%) 0.76 (0.49–1.18) 0.220 0.74 (0.47–1.17) 0.198
Emotion
At risk of depression (GDS ≥2 points) 22 (13.0%) 24 (14.2%) 1.11 (0.59–2.06) 0.751 1.11 (0.59–2.08) 0.749
Abbreviations: BADL basic activities of daily living, GDS geriatric depression scale, IADL instrumental activities of daily living, MMSE mini mental state exam, MNA
mini nutritional assessment, TUG timed get up and go test
a Adjustment variables include age, sex and Charlson comorbidity index
b Odds ratio (OR) with 95% confidence interval (CI) and p value from logistic regression for the comparison of follow-up vs. baseline status
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the prediction of nursing home admission including the
deceased patients, which showed no relevant change of
the predicting factors. Finally, this study only documents
associations of CGA with important outcomes, but, due
to the nature of a cohort study, fails to show whether or
not CGA ultimately improved patient outcomes. There-
fore, this study also has implications for research. Ran-
domized controlled trials are urgently needed to
determine the effect of CGA on outcomes in specific
clinical conditions, such as cardiologic, surgical or onco-
logic procedures [26].
Conclusion
This study shows that CGA is a useful tool to detect
functional deficits, which are associated with mortality
or nursing home admission after pacemaker implant-
ation. The present study seems to support the use of
CGA in older patients undergoing pacemaker implant-
ation as functional deficits and falls are amenable to
geriatric interventions.
Abbreviations
ADLs: Activities of daily living; BADL: Basic activities of daily living;
CCI: Charlson comorbidity index; CGA: Comprehensive geriatric assessment;
CI: Confidence interval; GDS: Geriatric depression scale; IADL: Instrumental
activities of daily living; IRR: Incidence rate ratio; MMSE: Mini mental state
exam; MNA: Mini nutritional assessment; OR: Odds ratio; TUG: Timed get up
and go test
Acknowledgements
We would like to thank the study nurses for helping with patient follow-up.
Fig. 2 a Kaplan-Meier survival estimates stratified by mobility at baseline. b Kaplan-Meier survival estimates stratified by nutritional status
at baseline
Schoenenberger et al. BMC Geriatrics          (2020) 20:287 Page 7 of 9
Authors’ contributions
AW has made substantial contributions to the design of the work, made
substantial contributions to the interpretation of the data and has drafted
the work. IR has made substantial contributions to the acquisition of the
data. BB has made substantial contributions to the acquisition of the data
and made substantial contributions to the interpretation of data. VW has
made substantial contributions to the acquisition of the data. RS has made
substantial contributions to the design of the work and has revised the work
substantively. PC has made substantial contributions to the interpretation of
data. RB has made substantial contributions to the acquisition of the data. FC
made substantial contributions to the interpretation of data and has
substantively revised the work. ST made substantial contributions to the
interpretation of data and has substantively revised the work. RK has made
substantial contributions to the design of the work, made substantial
contributions to the acquisition and interpretation of the data and has




Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request.
Ethics approval and consent to participate
This study complies with the Declaration of Helsinki and was approved by
the local ethics committee (Ethikkommission Nordwest- und Zentralschweiz,
Switzerland; committee’s reference number KEK Luzern 12045). Written
informed consent to participate in the study was obtained from all
participants.
Consent for publication
Written consent to publish their study results was obtained from all
participants.
Competing interests
RK has received institutional grant support from Abbott, Biotronik, Biosense
Webster, Boston, Medtronic and SIS Medical.
Author details
1Department of Geriatrics, Inselspital, Bern University Hospital, and University
of Bern, Bern, Switzerland. 2Heart Center Lucerne, Luzerner Kantonsspital,
6000 Lucerne 16, Switzerland. 3Department of Cardiology, University Hospital
Zurich, Zurich, Switzerland.
Received: 4 May 2019 Accepted: 31 July 2020
References
1. Fauchier L, Alonso C, Anselme F, Blangy H, Bordachar P, Boveda S, Clementy
N, Defaye P, Deharo JC, Friocourt P, Gras D, Halimi F, Klug D, Mansourati J,
Obadia B, Pasquié JL, Pavin D, Sadoul N, Taieb J, Piot O, Hanon O. Position
paper for management of elderly patients with pacemakers and
implantable cardiac defibrillators: Groupe de Rythmologie et Stimulation
Cardiaque de la Société Française de Cardiologie and Société Française de
Gériatrie et Gérontologie. Arch Cardiovasc Dis. 2016;109:563–85.
2. Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK,
Marinchak RA, Estes NA 3rd, Mitchell GF, Lieberman EH, Mangione CM,
Goldman L. Quality of life and clinical outcomes in elderly patients treated
with ventricular pacing as compared with dual-chamber pacing. Pacemaker
selection in the elderly investigators. N Engl J Med. 1998;338:1097–104.
3. Mandawat A, Curtis JP, Mandawat A, Njike VY, Lampert R. Safety of
pacemaker implantation in nonagenarians: an analysis of the healthcare
cost and utilization project-nationwide inpatient sample. Circulation. 2013;
127:1453–65.
4. Udo EO, van Hemel NM, Zuithoff NP, Kelder JC, Crommentuijn HA,
Koopman-Verhagen AM, Voskuil T, Doevendans PA, Moons KG. Long-term
outcome of cardiac pacing in octogenarians and nonagenarians. Europace.
2012;14(4):502–8.
5. Dang D, Galand V, Loirat A, Auffret V, Behar N, Mabo P, Daubert JC, Leclercq
C, Martins RP. Procedural safety and long-term follow-up after pacemaker
implantation in nonagenarians. Clin Cardiol. 2018;41:1315–21.
6. Schoenenberger AW, Stortecky S, Neumann S, Moser A, Jüni P, Carrel T,
Huber C, Gandon M, Bischoff S, Schoenenberger CM, Stuck AE, Windecker S,
Wenaweser P. Predictors of functional decline in elderly patients
undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J. 2013;
34:684–92.
7. Schoenenberger AW, Zuber C, Moser A, Zwahlen M, Wenaweser P,
Windecker S, Carrel T, Stuck AE, Stortecky S. Evolution of cognitive function
after transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2016;
9(10):e003590 Epub 2016 Sep 21.
8. Stortecky S, Schoenenberger AW, Moser A, Kalesan B, Jüni P, Carrel T,
Bischoff S, Schoenenberger CM, Stuck AE, Windecker S, Wenaweser P.
Evaluation of multidimensional geriatric assessment as a predictor of
mortality and cardiovascular events after transcatheter aortic valve
implantation. JACC Cardiovasc Interv. 2012;5:489–96.
9. Makary MA, Segev DL, Pronovost PJ, Syin D, Bandeen-Roche K, Patel P,
Takenaga R, Devgan L, Holzmueller CG, Tian J, Fried LP. Frailty as a predictor
of surgical outcomes in older patients. J Am Coll Surg. 2010;210:901–8.
10. Lee DH, Buth KJ, Martin BJ, Yip AM, Hirsch GM. Frail patients are at
increased risk for mortality and prolonged institutional care after cardiac
surgery. Circulation. 2010;121:973–8.
11. Afilalo J, Eisenberg MJ, Morin JF, Bergman H, Monette J, Noiseux N, Perrault
LP, Alexander KP, Langlois Y, Dendukuri N, Chamoun P, Kasparian G,
Robichaud S, Gharacholou SM, Boivin JF. Gait speed as an incremental
predictor of mortality and major morbidity in elderly patients undergoing
cardiac surgery. J Am Coll Cardiol. 2010;56:1668–76.
12. Schoenenberger AW, Moser A, Bertschi D, Wenaweser P, Windecker S, Carrel
T, Stuck AE, Stortecky S. Improvement of risk prediction after Transcatheter
aortic valve replacement by combining frailty with conventional risk scores.
JACC Cardiovasc Interv. 2018;11:395–403.
13. Ungar A, Mannarino G, van der Velde N, Baan J, Thibodeau MP, Masson JB,
Santoro G, van Mourik M, Jansen S, Deutsch C, Bramlage P, Kurucova J,
Thoenes M, Maggi S, Schoenenberger AW. Comprehensive geriatric
assessment in patients undergoing transcatheter aortic valve implantation -
results from the CGA-TAVI multicentre registry. BMC Cardiovasc Disord.
2018;18(1):1. https://doi.org/10.1186/s12872-017-0740-x.
14. Rubenstein LZ, Stuck AE. Multidimensional geriatric assessment. In: Sinclair
AJ, Morley JE, Vellas B, editors. Principles and Practice of Geriatric Medicine.
5th ed: Wiley; 2012. p. 1377–86. https://onlinelibrary.wiley.com/doi/book/1
0.1002/9781119952930#.Xy_2KwzBAkE.email.
15. Rockwood K, Dobbs AR, Rule BG, Howlett SE, Black WR. The impact of
pacemaker implantation on cognitive functioning in elderly patients. J Am
Geriatr Soc. 1992;40:142–6.
16. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G,
Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel
CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE, ESC
Committee for Practice Guidelines (CPG), Zamorano JL, Achenbach S,
Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari
R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A,
Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL,
Tendera M, Torbicki A, Wijns W, Windecker S, Document Reviewers, Kirchhof
P, Blomstrom-Lundqvist C, Badano LP, Aliyev F, Bänsch D, Baumgartner H,
Bsata W, Buser P, Charron P, Daubert JC, Dobreanu D, Faerestrand S, Hasdai
D, Hoes AW, Heuzey JY, Mavrakis H, McDonagh T, Merino JL, Nawar MM,
Nielsen JC, Pieske B, Poposka L, Ruschitzka F, Tendera M, Van Gelder IC,
Wilson CM. 2013 ESC Guidelines on cardiac pacing and cardiac
resynchronization therapy: the task force on cardiac pacing and
resynchronization therapy of the European Society of Cardiology (ESC).
Developed in collaboration with the European heart rhythm association
(EHRA). Eur Heart J. 2013;34:2281–329.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying
prognostic comorbidity in longitudinal studies: development and validation.
J Chronic Dis. 1987;40:373–83.
18. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical
method for grading the cognitive state of patients for the clinician. J
Psychiatr Res. 1975;12:189–98.
19. Podsiadlo D, Richardson S. The timed “up & go”: a test of basic functional
mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–8.
Schoenenberger et al. BMC Geriatrics          (2020) 20:287 Page 8 of 9
20. Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition.
The mini nutritional assessment. Clin Geriatr Med. 2002;18:737–57.
21. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in
the aged. The index of ADL: a standardized measure of biological and
psychosocial function. JAMA. 1963;185:914–9.
22. Lawton MP, Brody EM. Assessment of older people: self-maintaining and
instrumental activities of daily living. Gerontologist. 1969;9:179–86.
23. Hoyl MT, Alessi CA, Harker JO, Josephson KR, Pietruszka FM, Koelfgen M,
Mervis JR, Fitten LJ, Rubenstein LZ. Development and testing of a five-item
version of the geriatric depression scale. J Am Geriatr Soc. 1999;47:873–8.
24. Krzemień-Wolska K, Tomasik A, Wojciechowska C, Barańska-Pawełczak K,
Nowalany-Kozielska E, Jacheć W. Prognostic factors in patients with an
implanted pacemaker after 80 years of age in a 4-year follow-up.
Gerontology. 2018;64:107–17.
25. Steinbach M, Douchet MP, Bakouboula B, Bronner F, Chauvin M. Outcome
of patients aged over 75 years who received a pacemaker to treat sinus
node dysfunction. Arch Cardiovasc Dis. 2011;104:89–96.
26. Puts MT, Hsu T, Mariano C, Monette J, Brennenstuhl S, Pitters E, Ray J, Wan-
Chow-Wah D, Kozlowski N, Krzyzanowska M, Amir E, Elser C, Jang R, Prica A,
Krahn M, Beland F, Bergman S, Koneru R, Lemonde M, Szumacher E, Zidulka
J, Fung S, Li A, Emmenegger U, Mehta R, Flemming K, Breunis H, Alibhai
SM. Clinical and Cost-effectiveness of a Comprehensive geriatric assessment
and management for Canadian elders with Cancer-the 5C study: a study
protocol for a randomised controlled phase III trial. BMJ Open. 2019;9(5):
e024485.
27. Bachmann S, Finger C, Huss A, Egger M, Stuck AE, Clough-Gorr KM.
Inpatient rehabilitation specifically designed for geriatric patients: systematic
review and meta-analysis of randomised controlled trials. BMJ. 2010;340:
c1718.
28. Ellis G, Whitehead MA, Robinson D, O’Neill D, Langhorne P. Comprehensive
geriatric assessment for older adults admitted to hospital: meta-analysis of
randomised controlled trials. BMJ. 2011;343:d6553.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Schoenenberger et al. BMC Geriatrics          (2020) 20:287 Page 9 of 9
